Investing.com -- Stereotaxis Inc. (NYSE:STXS) shares fell 7% in after-hours trading Tuesday after the surgical robotics company reported third-quarter revenue that missed analyst expectations and ...

The transaction would strengthen KARL STORZ's position in the robotic surgical market. The transaction is anticipated to close during the third quarter of 2024. From tariffs to inflation, macro risks ...

Stereotaxis received clearance from the Food & Drug Administration for its latest surgical robotic system, GenesisX. The maker of surgical robots on Monday said the GenesisX builds upon the benefits ...

Shares of medical products company UFP Technologies (NASDAQ:UFPT) jumped 16.2% in the morning session after the company ...

GitLab (NASDAQ: GTLB) is another high-gross-margin SaaS company trading at bargain-bin levels. The stock carries a forward P/S multiple of under 7 times despite consistently growing its revenue above ...

Fitell Corp. (NASDAQ:FTEL) shares jumped 7.28% in after-hours trading on Thursday, reaching $1.62. Check out the current price of FTEL stock here.

The integration of AI and GenAI has transformed trading desks, revolutionising workflows and reshaping decision-making processes. However, the rise of AI raises critical questions about the evolving ...

On Friday, KARL STORZ Endoscopy-America, Inc. agreed to acquire Asensus Surgical Inc. (NYSE:ASXC) for $0.35 per share in cash. KARL STORZ is a wholly-owned direct subsidiary of KARL STORZ SE & Co. KG, ...